Skip to content
Products
Multiples
EV/Sales & EV/EBITDA for private markets
Startup Valuation Engine
Berkus, VC method, First Chicago and more
Industry Coverage
Deals Monitor
Deal of the Week
Deal of the Month
Deal of the Year
Resources
Featured
Private Company Valuation Guide
The complete practitioner's guide: multiples, CCA, PTA, DCF and IPEV 2025.
Open guide
Valuation Multiples Explained
Understand and correctly apply EV/Sales and EV/EBITDA.
Read article
More resources
Blog
Latest articles on private-market valuation and deals.
Private Company Valuation Guide
Evergreen guide: methods, multiples, IPEV, glossary.
Multiples Methodology
The 6-step methodology behind DealMatrix multiples.
Valuation Methods
Berkus, Payne Scorecard, VC Method, First Chicago.
Pricing
Log in
29.04.2024
Deal of the Week
|
Calendar Week #
18
|
2024
Dutch startup Vitestro $22M for revolutionary autonomous blood drawing device
HQ:
NL
Founded: 2017
Series A
Sector:
Healthcare
Investment Raised: ER 20M €
Valuation Remains Undisclosed
Investors: Sonder Capital NYBC Ventures Inves-NL European Innovation Council
News Link
22.04.2024
Deal of the Week
|
Calendar Week #
17
|
2024
CN Bio raises $21 million to scale up organ-on-a-chip technology
HQ:
UK
Founded: 2009
Series B
Sector:
Biotechnology
Investment Raised: USD 21M €
Valuation Remains Undisclosed
Investors: CN Innovations Bayland Capital
News Link
15.04.2024
Deal of the Week
|
Calendar Week #
16
|
2024
Finland’s satellite imaging startup ICEYE raises oversubscribed €87M growth funding round
HQ:
FI
Founded: 2014
Venture – Series Unknown
Sector:
Aerospace
Investment Raised: EUR 87M €
Valuation Remains Undisclosed
Investors: Solidium Move Capital Blackwells Capital Christo Georgiev
News Link
08.04.2024
Deal of the Week
|
Calendar Week #
15
|
2024
Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments
HQ:
DK
Founded: 2018
Series A
Sector:
Biotechnology
Investment Raised: USD 20M €
Valuation Remains Undisclosed
Investors: Y Combinator R7 Partners Per Falholt Nicholas Francis Astanor Ventures ACME Capital 21st.BIO
News Link
01.04.2024
Deal of the Month
|
April |
2024
Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders
HQ:
CH
Founded: 2024
Series A
Investment Raised: USD 63M €
Valuation Remains Undisclosed
Investors: Perceptive Life Sciences Perceptive Advisors Acorn Bioventures
News Link
01.04.2024
Deal of the Week
|
Calendar Week #
14
|
2024
Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological Disorders
HQ:
CH
Founded: 2024
Series A
Sector:
Biotechnology
Investment Raised: USD 63M €
Valuation Remains Undisclosed
Investors: Perceptive Life Sciences Perceptive Advisors Acorn Bioventures
News Link
